---
The symbiote is back, and this time, it's personal.
Sony's Venom franchise has always been the black sheep of the superhero world—ugly, unpredictable, and absolutely addictive. After the original film raked in over $850 million globally in 2018, followed by the sequel's solid $500 million haul despite pandemic-era release chaos, the franchise has proven it doesn't need Spider-Man to carry it. Venom stands on his own two goo-covered legs, and audiences can't get enough.
Now, "Venom: The Last Dance" is gearing up for what analysts are calling a massive $70 million opening weekend—and honestly, that number feels conservative.
What makes this franchise so reliably profitable? It's not the glossy Marvel polish or the multiverse tying headaches. It's the whole package: Tom Hardy giving one of the most unhinged performances in modern superhero cinema, paired with that darkly comedic edge where you're never quite sure if the alien in someone's head is going to save the day or eat the bad guy's face. The trailers have been teasing exactly that—a chaotic, heart-pounding conclusion to a saga that's been building for six years.
The October release timing is also genius. Halloween season means audiences are actively hunting for something ghoulish and fun, and Venom delivers that in spades. The franchise has always leaned into the macabre, and that timing creates a perfect storm of marketing momentum and cultural timing.
If "The Last Dance" hits those numbers—and everything points to it will—it sends a clear message to every studio paying attention: you don't need a shared universe to build a billion-dollar franchise. Sometimes one grumpy symbiote is all it takes.
The dance isn't over. It's just getting started.
